Standout Papers

Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta... 2022 2026 2023 2024386
  1. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants (2022)
    Emma K. Accorsi, Amadea Britton et al. JAMA
  2. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 (2022)
    Miwako Kobayashi, Jennifer L. Farrar et al. MMWR Morbidity and Mortality Weekly Report
  3. Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023 (2023)
    Michael Melgar, Amadea Britton et al. MMWR Morbidity and Mortality Weekly Report
  4. Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023 (2023)
    Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report
  5. Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, September 2023–January 2024 (2024)
    Ruth Link‐Gelles, Allison Avrich Ciesla et al. MMWR Morbidity and Mortality Weekly Report
  6. Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 (2024)
    Amadea Britton, Lauren E. Roper et al. MMWR Morbidity and Mortality Weekly Report

Immediate Impact

1 by Nobel laureates 5 from Science/Nature 64 standout
Sub-graph 1 of 20

Citing Papers

Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
A natural experiment on the effect of herpes zoster vaccination on dementia
2025 StandoutNature
3 intermediate papers

Works of Amadea Britton being referenced

1935. COVID-19 mRNA Vaccination Reduces the Occurrence of Post-COVID Conditions in U.S. Children Aged 5-17 Years Following Omicron SARS-CoV-2 Infection, July 2021-September 2022
2023
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
2022 Standout

Author Peers

Author Last Decade Papers Cites
Amadea Britton 918 509 418 23 1.4k
Sharon Gray 751 400 385 28 1.2k
Kayla E. Hanson 655 277 295 32 1.4k
Sarah A. Buchan 1237 621 480 90 2.0k
Farid Khan 1187 496 626 35 1.8k
Danielle Moulia 751 320 406 31 1.3k
Yi Luo 658 728 279 71 1.4k
Nancy McClung 761 264 661 15 1.5k
Ashley Fowlkes 726 1069 213 39 1.7k
Sarah Mbaeyi 617 698 624 25 1.6k
Tanya R. Myers 1181 225 650 48 1.9k

All Works

Loading papers...

Rankless by CCL
2026